May TGFBR1 act also as low penetrance allele in Marfan syndrome?

Laura Lucarini, Lucia Evangelisti, Monica Attanasio, Ilaria Lapini, Francesca Chiarini, Maria Cristina Porciani, Rosanna Abbate, GianFranco Gensini, Guglielmina Pepe

Research output: Contribution to journalArticlepeer-review


Marfan syndrome, a human disease involving cardiovascular and skeletal apparatuses and ocular and central nervous systems, is associated to mutations in FBN1 gene; heterozygous mutations in TGFBR2 and TGFBR1 genes were found associated to MFS type 2, characterized by the presence of skeletal and cardiovascular major criteria and absence of eye major criterion. We screened the TGFBR1 gene in 46 Marfan patients in whom mutations in FBN1 and TGFBR2 genes were excluded and the analysis of Ex1 was extended to additional 114 Marfan patients and 237 controls. We detected two potentially pathological sequence variants: the TGFBR1 6Ala allele whose frequency was higher in the group of Marfan patients (0.13) than in the controls (0.08) (p = 0.013; OR = 1.69) and an insertion of 20 nucleotides in the 5′UTR that turned out to be a familial silent rare polymorphism. We hypothesize that TGFBR1 sequence variants may act not only as major, but also as low penetrance alleles of the clinical phenotype in Marfan syndrome.

Original languageEnglish
Pages (from-to)281-284
Number of pages4
JournalInternational Journal of Cardiology
Issue number2
Publication statusPublished - Jan 9 2009


  • Marfan syndrome
  • MFS type 2
  • TGFBR1
  • TGFBR1 6Ala allele

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'May TGFBR1 act also as low penetrance allele in Marfan syndrome?'. Together they form a unique fingerprint.

Cite this